AI Screening for Diabetic Retinopathy - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AI Screening for Diabetic Retinopathy

  • By

  • Abraham Olvera-Barrios, MD, PhD

  • Cathy Egan, FRANZCO

  • May 1, 2026

  • 18 min

Share

  • 1

    Diabetes mellitus affects 1 in 9 adults globally, with 589 million cases projected by 2024 and 853 million by 2050.

  • 2

    Diabetic retinopathy affects 30% of individuals with diabetes and is a leading cause of preventable blindness among working-age adults.

  • 3

    Automated retinal image analysis systems (ARIAS) powered by AI are emerging as scalable solutions for diabetic eye screening due to workforce shortages.

  • 4

    Several AI systems have received regulatory clearance, but real-world deployment requires high performance in detecting high-risk diabetic retinopathy.

  • 5

    Centralized screening programs are essential for effective diabetic retinopathy screening, as demonstrated by successful models in the UK and Iceland.

Original Source(s)

AI Screening for Diabetic Retinopathy

  • by Abraham Olvera-Barrios, MD, PhD, Cathy Egan, FRANZCO

  • May 1, 2026

Related Content

The association between estimated glucose disposal rate and self-reported diabetic retinopathy: evidence from two independent cohorts and machine learning

Sympathetic ophthalmia complicating proliferative diabetic retinopathy: diagnostic and therapeutic challenges during pregnancy

AI Tool May Cut Macular Edema Referrals

An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.